Literature DB >> 9154783

Long-term results of laparoscopic Burch urethropexy.

R W Lobel1, G D Davis.   

Abstract

STUDY
OBJECTIVE: To evaluate the long-term efficacy of laparoscopic Burch urethropexy.
DESIGN: Pilot study.
SETTING: Private practice. PATIENTS: Thirty-five consecutive women (average age 45.5 yrs, average parity 2.3, average weight 67.7 kg) treated for genuine stress incontinence between May 1992 and July 1994.
INTERVENTIONS: Urethropexy was performed with curved needle suturing in 7 women, straight needle suturing in 5, and Stamey needle suturing in 23. Twenty-five (71.4%) patients had concomitant pelvic surgery.
MEASUREMENTS AND MAIN RESULTS: Wilcoxon two-sample, chi2, and Fisher's exact tests were performed to determine which variables were significantly associated with surgical success. Average operating time was 190 minutes, hospitalization 24 hours, and catheterization 5 days. The cure rate of stress incontinence was 89% 3 months and 86% 1 year after surgery. At average follow-up of 34 months, only 68.6% of patients reported complete or almost complete cure, 11.4% were improved, and 20% were complete failures. The only operative variable approaching statistical significance for predicting surgical success was type of suture needle (p = 0.07), with the Stamey needle group having the highest cure rate. Women who were cured or almost cured had a significantly shorter follow-up than those who were improved or failures (p = 0.001).
CONCLUSION: The success rate of laparoscopic Burch urethropexy compares with that of open Burch procedure at 1 year, but drops considerably thereafter.

Entities:  

Mesh:

Year:  1997        PMID: 9154783     DOI: 10.1016/s1074-3804(05)80225-7

Source DB:  PubMed          Journal:  J Am Assoc Gynecol Laparosc        ISSN: 1074-3804


  1 in total

1.  Stress urinary incontinence: long-term results of laparoscopic Burch colposuspension.

Authors:  Domenico Prezioso; Fabrizio Iacono; Giovanni Di Lauro; Ester Illiano; Giuseppe Romeo; Antonio Ruffo; Nicola Russo; Bruno Amato
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.